Payment overview · 2025
General Payments
$592.34
29 reported records · 14 companies
Healthcare provider profile · identity verified
Mustafa Rahim, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · BECKLEY, WV · NPI 1831289891
Verified facts
What the public records show
CMS Open Payments records show Mustafa Rahim, M.D. received $592.34 in general payments during 2025 across 29 reported records.
Lundbeck LLC accounted for 13.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 16 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Creon, Jardiance, Linzess, Ozempic.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 239 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 68 claims for Synthroid by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 105 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 90 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LOKELMA as an associated drug or biological on 6897 records involving 4326 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Lokelma by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 22 claims for Symbicort by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 280 claims for Jardiance by this doctor in 2024.
Novartis Pharmaceuticals Corporation reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ENTRESTO as an associated drug or biological on 9346 records involving 6254 distinct recipient NPIs. Public Medicare Part D data also shows 313 claims for Entresto by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 409 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lundbeck LLC | Unresolved — no canonical attribution shown | $82.61 | 13.9% | 4 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $82.53 | 13.9% | 4 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $73.18 | 12.3% | 3 | 2025 |
| Verona Pharma, Inc. | Unresolved — no canonical attribution shown | $69.85 | 11.8% | 3 | 2025 |
| Tandem Diabetes Care, Inc. | Unresolved — no canonical attribution shown | $52.07 | 8.8% | 3 | 2025 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | Unresolved — no canonical attribution shown | $47.56 | 8.0% | 2 | 2025 |
| Aimmune Therapeutics, Inc. | Unresolved — no canonical attribution shown | $41.51 | 7.0% | 2 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $38.67 | 6.5% | 2 | 2025 |
| KYOWA KIRIN, INC. | Unresolved — no canonical attribution shown | $23.46 | 4.0% | 1 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $22.78 | 3.9% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $22.22 | 3.8% | 1 | 2025 |
| Novartis Pharmaceuticals Corporation | Unresolved — no canonical attribution shown | $18.08 | 3.0% | 1 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $15.70 | 2.6% | 1 | 2025 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Unresolved — no canonical attribution shown | $2.12 | 0.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $592.34 | 29 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC, Otsuka Pharmaceutical Development & Commercialization, Inc. | $130.17 | 6 | 2025 |
Source payment records
|
|||||
| Ohtuvayre Normalized: ohtuvayre |
Drug | Verona Pharma, Inc. | $69.85 | 3 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $59.73 | 3 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $59.73 | 3 | 2025 |
Source payment records
|
|||||
| t:slim X2 Insulin Pump with Control-IQ Normalized: t slim x2 insulin pump with control iq |
Device | Tandem Diabetes Care, Inc. | $52.07 | 3 | 2025 |
Source payment records
|
|||||
| LINZESS Normalized: linzess |
Drug | ABBVIE INC. | $43.90 | 2 | 2025 |
Source payment records
|
|||||
| VOWST Normalized: vowst |
Biological | Aimmune Therapeutics, Inc. | $41.51 | 2 | 2025 |
Source payment records
|
|||||
| VERQUVO Normalized: verquvo |
Drug | Merck Sharp & Dohme LLC | $38.67 | 2 | 2025 |
Source payment records
|
|||||
| CREON Normalized: creon |
Drug | ABBVIE INC. | $29.28 | 1 | 2025 |
Source payment records
|
|||||
| CRYSVITA Normalized: crysvita |
Drug | KYOWA KIRIN, INC. | $23.46 | 1 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $22.78 | 1 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 2 Normalized: freestyle libre 2 |
Device | Abbott Laboratories | $22.22 | 1 | 2025 |
Source payment records
|
|||||
| LEQVIO Normalized: leqvio |
Drug | Novartis Pharmaceuticals Corporation | $18.08 | 1 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $15.70 | 1 | 2025 |
Source payment records
|
|||||
| CAPVAXIVE Normalized: capvaxive |
Biological | Merck Sharp & Dohme LLC | $15.51 | 1 | 2025 |
Source payment records
|
|||||
| LifeVest Normalized: lifevest |
Device | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $2.12 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| CREON creon |
2025 | Creon | 2024 | 11 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 280 | exact normalized | Medicare Part D |
| LINZESS linzess |
2025 | Linzess | 2024 | 239 | exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 409 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
239 | 32 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
68 | 21 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
105 | 21 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
90 | 20 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | LOKELMA open payments reported associated product |
CMS Open Payments — General Payments 6897 supporting records · 4326 recipient NPIs · example record 1206131624 |
Lokelma · 2024 Exact normalized brand match · 1 Part D row |
26 | 14 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
22 | 13 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
280 | 52 |
| Novartis Pharmaceuticals Corporation Exact reporting entity; no affiliate inference |
2025 | ENTRESTO open payments reported associated product |
CMS Open Payments — General Payments 9346 supporting records · 6254 recipient NPIs · example record 1200004797 |
Entresto · 2024 Exact normalized brand match · 1 Part D row |
313 | 54 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
409 | 71 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 3186 | 487 |
| Levothyroxine Sodium | Levothyroxine Sodium | 2508 | 313 |
| Pantoprazole Sodium | Pantoprazole Sodium | 2227 | 336 |
| Lisinopril | Lisinopril | 1579 | 242 |
| Furosemide | Furosemide | 1322 | 200 |
| Simvastatin | Simvastatin | 1234 | 198 |
| Gabapentin | Gabapentin | 1093 | 121 |
| Eliquis | Apixaban | 1038 | 136 |
| Duloxetine Hcl | Duloxetine Hcl | 1034 | 174 |
| Metoprolol Tartrate | Metoprolol Tartrate | 1019 | 139 |
| Potassium Chloride | Potassium Chloride | 998 | 168 |
| Metoprolol Succinate | Metoprolol Succinate | 995 | 199 |
| Tamsulosin Hcl | Tamsulosin Hcl | 957 | 150 |
| Clopidogrel | Clopidogrel Bisulfate | 934 | 142 |
| Omeprazole | Omeprazole | 876 | 141 |
| Amlodipine Besylate | Amlodipine Besylate | 855 | 144 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 821 | 77 |
| Losartan Potassium | Losartan Potassium | 813 | 146 |
| Nifedipine Er | Nifedipine | 783 | 127 |
| Metformin Hcl | Metformin Hcl | 741 | 105 |
| Montelukast Sodium | Montelukast Sodium | 677 | 92 |
| Fluticasone Propionate | Fluticasone Propionate | 602 | 138 |
| Trazodone Hcl | Trazodone Hcl | 598 | 100 |
| Tizanidine Hcl | Tizanidine Hcl | 556 | 110 |
| Famotidine | Famotidine | 549 | 85 |
| Tramadol Hcl | Tramadol Hcl | 519 | 66 |
| Donepezil Hcl | Donepezil Hcl | 509 | 43 |
| Divalproex Sodium | Divalproex Sodium | 503 | 43 |
| Lorazepam | Lorazepam | 495 | 42 |
| Clonidine Hcl | Clonidine Hcl | 472 | 84 |
| Levetiracetam | Levetiracetam | 470 | 45 |
| Meloxicam | Meloxicam | 470 | 85 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 454 | 109 |
| Mirtazapine | Mirtazapine | 451 | 76 |
| Tradjenta | Linagliptin | 444 | 69 |
| Buspirone Hcl | Buspirone Hcl | 443 | 71 |
| Glipizide | Glipizide | 425 | 78 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 420 | 72 |
| Ropinirole Hcl | Ropinirole Hcl | 416 | 79 |
| Ozempic | Semaglutide | 409 | 71 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 406 | 118 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 404 | 76 |
| Carvedilol | Carvedilol | 391 | 61 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 382 | 81 |
| Ezetimibe | Ezetimibe | 360 | 59 |
| Hydrochlorothiazide | Hydrochlorothiazide | 351 | 66 |
| Allopurinol | Allopurinol | 349 | 55 |
| Sertraline Hcl | Sertraline Hcl | 341 | 51 |
| Pregabalin | Pregabalin | 332 | 57 |
| Doxycycline Hyclate | Doxycycline Hyclate | 318 | 203 |
| Entresto | Sacubitril/Valsartan | 313 | 54 |
| Benztropine Mesylate | Benztropine Mesylate | 299 | 32 |
| Jardiance | Empagliflozin | 280 | 52 |
| Fluoxetine Hcl | Fluoxetine Hcl | 263 | 26 |
| Quetiapine Fumarate | Quetiapine Fumarate | 252 | 31 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 248 | 28 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 240 | 62 |
| Linzess | Linaclotide | 239 | 32 |
| Clozapine | Clozapine | 236 | suppressed |
| Prednisone | Prednisone | 230 | 148 |
| Januvia | Sitagliptin Phosphate | 221 | 28 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 213 | 20 |
| Memantine Hcl | Memantine Hcl | 212 | 28 |
| Xarelto | Rivaroxaban | 211 | 25 |
| Cilostazol | Cilostazol | 205 | 41 |
| Clonazepam | Clonazepam | 193 | 24 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 186 | 22 |
| Midodrine Hcl | Midodrine Hcl | 185 | 45 |
| Citalopram Hbr | Citalopram Hydrobromide | 184 | 31 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 181 | 35 |
| Risperidone | Risperidone | 178 | 24 |
| Meclizine Hcl | Meclizine Hcl | 176 | 40 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 176 | 17 |
| Finasteride | Finasteride | 170 | 32 |
| Myrbetriq | Mirabegron | 168 | 28 |
| Spironolactone | Spironolactone | 168 | 45 |
| Alendronate Sodium | Alendronate Sodium | 162 | 30 |
| Celecoxib | Celecoxib | 153 | 17 |
| Labetalol Hcl | Labetalol Hcl | 152 | 24 |
| Ventolin Hfa | Albuterol Sulfate | 150 | 36 |
| Ranolazine Er | Ranolazine | 147 | 21 |
| Tresiba Flextouch U-100 | Insulin Degludec | 144 | 34 |
| Ziprasidone Hcl | Ziprasidone Hcl | 144 | suppressed |
| Trulicity | Dulaglutide | 140 | 19 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 139 | 20 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 135 | 19 |
| Warfarin Sodium | Warfarin Sodium | 135 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 132 | 11 |
| Nitroglycerin | Nitroglycerin | 132 | 55 |
| Hydralazine Hcl | Hydralazine Hcl | 130 | 31 |
| Pravastatin Sodium | Pravastatin Sodium | 128 | 26 |
| Amiodarone Hcl | Amiodarone Hcl | 127 | 28 |
| Sucralfate | Sucralfate | 127 | 27 |
| Candesartan Cilexetil | Candesartan Cilexetil | 124 | 22 |
| Carbamazepine | Carbamazepine | 121 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 121 | 14 |
| Olanzapine | Olanzapine | 118 | 15 |
| Methotrexate | Methotrexate Sodium | 117 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 115 | 31 |
| Clobetasol Propionate | Clobetasol Propionate | 113 | 41 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 110 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 107 | 36 |
| Brilinta | Ticagrelor | 105 | 21 |
| Ibuprofen | Ibuprofen | 105 | 24 |
| Calcitriol | Calcitriol | 103 | 16 |
| Amitriptyline Hcl | Amitriptyline Hcl | 101 | 17 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 100 | 21 |
| Nystatin | Nystatin | 99 | 39 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 98 | 20 |
| Ketoconazole | Ketoconazole | 94 | 46 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 93 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 93 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 92 | 21 |
| Metoclopramide Hcl | Metoclopramide Hcl | 92 | 15 |
| Farxiga | Dapagliflozin Propanediol | 90 | 20 |
| Topiramate | Topiramate | 90 | 17 |
| Cimetidine | Cimetidine | 89 | 12 |
| Baclofen | Baclofen | 88 | 19 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 87 | 82 |
| Lamotrigine | Lamotrigine | 87 | 14 |
| Cefdinir | Cefdinir | 86 | 72 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 86 | 19 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 86 | 18 |
| Lactulose | Lactulose | 86 | 20 |
| Alprazolam | Alprazolam | 84 | suppressed |
| Amoxicillin | Amoxicillin | 84 | 72 |
| Bupropion Xl | Bupropion Hcl | 84 | 12 |
| Divalproex Sodium Er | Divalproex Sodium | 82 | 11 |
| Mupirocin | Mupirocin | 81 | 39 |
| Roflumilast | Roflumilast | 81 | 15 |
| Propranolol Hcl | Propranolol Hcl | 80 | 12 |
| Atenolol | Atenolol | 79 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 79 | 20 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 79 | 15 |
| Doxazosin Mesylate | Doxazosin Mesylate | 78 | 15 |
| Ondansetron Hcl | Ondansetron Hcl | 78 | 36 |
| Valsartan | Valsartan | 76 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 74 | 14 |
| Bupropion Hcl Sr | Bupropion Hcl | 73 | 13 |
| Dutasteride | Dutasteride | 73 | 15 |
| Levemir Flexpen | Insulin Detemir | 72 | 20 |
| Novolog Flexpen | Insulin Aspart | 71 | 16 |
| Azithromycin | Azithromycin | 69 | 63 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 69 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 68 | suppressed |
| Minoxidil | Minoxidil | 68 | 16 |
| Synthroid | Levothyroxine Sodium | 68 | 21 |
| Ondansetron Odt | Ondansetron | 67 | 28 |
| Enulose | Lactulose | 64 | 12 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 64 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 64 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 63 | 27 |
| Digoxin | Digoxin | 63 | 13 |
| Latanoprost | Latanoprost | 63 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 63 | 20 |
| Colestipol Hcl | Colestipol Hcl | 62 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 62 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 62 | 43 |
| Oxybutynin Chloride | Oxybutynin Chloride | 61 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 61 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 61 | suppressed |
| Sotalol | Sotalol Hcl | 60 | suppressed |
| Theo-24 | Theophylline Anhydrous | 60 | suppressed |
| Clonidine | Clonidine | 58 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 57 | 17 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 56 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 55 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 53 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 52 | 13 |
| Fluconazole | Fluconazole | 52 | 41 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 51 | 14 |
| Lidocaine | Lidocaine | 51 | 13 |
| Torsemide | Torsemide | 50 | 14 |
| Glimepiride | Glimepiride | 49 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 49 | 18 |
| Cephalexin | Cephalexin | 48 | 37 |
| Naltrexone Hcl | Naltrexone Hcl | 48 | suppressed |
| Naproxen | Naproxen | 48 | 12 |
| Glipizide Er | Glipizide | 46 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 45 | 31 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 45 | 35 |
| Aripiprazole | Aripiprazole | 44 | 12 |
| Atrovent Hfa | Ipratropium Bromide | 44 | 11 |
| Doxepin Hcl | Doxepin Hcl | 44 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 43 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 43 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 42 | 12 |
| Diazepam | Diazepam | 40 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 40 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 39 | 14 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 39 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 38 | 18 |
| Mounjaro | Tirzepatide | 38 | suppressed |
| Otezla | Apremilast | 38 | suppressed |
| Repatha Sureclick | Evolocumab | 38 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 37 | suppressed |
| Austedo | Deutetrabenazine | 37 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 37 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 37 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 34 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 34 | suppressed |
| Haloperidol | Haloperidol | 33 | suppressed |
| Levofloxacin | Levofloxacin | 33 | 29 |
| Methocarbamol | Methocarbamol | 33 | suppressed |
| Scopolamine | Scopolamine | 33 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 32 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 32 | 11 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 31 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 31 | suppressed |
| Nystop | Nystatin | 31 | 16 |
| Timolol Maleate | Timolol Maleate | 31 | suppressed |
| Azelastine-Fluticasone | Azelastine/Fluticasone | 30 | 15 |
| Carbamazepine Er | Carbamazepine | 30 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 30 | suppressed |
| Ramelteon | Ramelteon | 30 | suppressed |
| Klor-Con M20 | Potassium Chloride | 29 | 12 |
| Sevelamer Carbonate | Sevelamer Carbonate | 29 | suppressed |
| Xifaxan | Rifaximin | 29 | suppressed |
| Alogliptin | Alogliptin Benzoate | 28 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 28 | suppressed |
| Budesonide | Budesonide | 28 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 28 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 28 | 24 |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 28 | 11 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 27 | 27 |
| Ammonium Lactate | Ammonium Lactate | 27 | 18 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 27 | 26 |
| Folic Acid | Folic Acid | 27 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 27 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 27 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 26 | suppressed |
| Humalog | Insulin Lispro | 26 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 26 | 14 |
| Norethindrone Acetate | Norethindrone Acetate | 26 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 26 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 26 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 25 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 25 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 25 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 24 | suppressed |
| Klor-Con | Potassium Chloride | 24 | suppressed |
| Lansoprazole | Lansoprazole | 24 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 24 | suppressed |
| Anastrozole | Anastrozole | 23 | suppressed |
| Bumetanide | Bumetanide | 23 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 23 | suppressed |
| Humulin R | Insulin Regular, Human | 23 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 23 | suppressed |
| Novolog | Insulin Aspart | 23 | suppressed |
| Ramipril | Ramipril | 23 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 23 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 23 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 22 | suppressed |
| Lacosamide | Lacosamide | 22 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 22 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 22 | 13 |
| Terazosin Hcl | Terazosin Hcl | 22 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 22 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 21 | suppressed |
| Estradiol | Estradiol | 21 | suppressed |
| Gvoke Hypopen 2-Pack | Glucagon | 21 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 21 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 21 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 20 | 15 |
| Meropenem-0.9% Nacl | Meropenem-0.9% Sodium Chloride | 20 | suppressed |
| Clotrimazole | Clotrimazole | 19 | 15 |
| Cyclosporine | Cyclosporine | 19 | suppressed |
| Hydrocortisone | Hydrocortisone | 19 | suppressed |
| Levemir | Insulin Detemir | 19 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 19 | suppressed |
| Carbidopa-Levodopa-Entacapone | Carbidopa/Levodopa/Entacapone | 18 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 18 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 18 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 18 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 18 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 18 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 18 | suppressed |
| Nabumetone | Nabumetone | 18 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 18 | 15 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) | Insulin Pump Cart,auto,bt,g6/7 | 18 | suppressed |
| Phenobarbital | Phenobarbital | 18 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 18 | suppressed |
| Mupirocin | Mupirocin Calcium | 17 | 12 |
| Raloxifene Hcl | Raloxifene Hcl | 17 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 17 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 17 | suppressed |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 16 | suppressed |
| Insulin Lispro | Insulin Lispro | 16 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 16 | suppressed |
| Lubiprostone | Lubiprostone | 16 | suppressed |
| Rivastigmine | Rivastigmine | 16 | suppressed |
| Amantadine | Amantadine Hcl | 15 | suppressed |
| Cholestyramine Light | Cholestyramine | 15 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 15 | suppressed |
| Kerendia | Finerenone | 15 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 15 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 14 | suppressed |
| Methylprednisolone | Methylprednisolone | 14 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 14 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 14 | suppressed |
| Primidone | Primidone | 14 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 14 | suppressed |
| Vascepa | Icosapent Ethyl | 14 | suppressed |
| Entacapone | Entacapone | 13 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 13 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Levetiracetam Er | Levetiracetam | 13 | suppressed |
| Novolin R | Insulin Regular, Human | 13 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 12 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 12 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 12 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 12 | suppressed |
| Lyrica | Pregabalin | 12 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 12 | suppressed |
| Omnipod 5 Dexg7g6 Intro(Gen 5) | Insulin Pmp Cart,aut,g6/7,cntr | 12 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 12 | suppressed |
| Sulfasalazine | Sulfasalazine | 12 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Dulera | Mometasone/Formoterol | 11 | suppressed |
| Indomethacin | Indomethacin | 11 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Premarin | Estrogens, Conjugated | 11 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $592.34 · 29 records | Lundbeck LLC | AIRSUPRA, CAPVAXIVE, CREON, CRYSVITA, FREESTYLE LIBRE 2, JARDIANCE, LEQVIO, LINZESS, LifeVest, Ohtuvayre, Ozempic, REXULTI, Rybelsus, VERQUVO, VOWST, t:slim X2 Insulin Pump with Control-IQ | 10 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Creon play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error